Greenwich LifeSciences (GLSI) Return on Assets (2020 - 2025)
Greenwich LifeSciences (GLSI) posted Return on Assets of 0.06% for Q4 2025, up 28.34% on a QoQ basis from 0.08% in Q3 2025, and down 1.0% year-over-year from 0.06% in Q4 2024.
Greenwich LifeSciences (GLSI) Return on Assets (2020 - 2025) Analysis & Trends
Greenwich LifeSciences' Return on Assets history runs 6 years deep, the most recent figure standing at 0.06% for Q4 2025.
- Quarterly Return on Assets fell 1.0% year-over-year to 0.06% in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 0.06% (down 1.0% YoY) and the FY2025 annual result came in at 0.06%, down 1.0% from the prior year.
- Return on Assets was 0.06% for Q4 2025 at Greenwich LifeSciences, up from 0.08% in the prior quarter.
- Across five years, Return on Assets topped out at 0.0% in Q1 2021 and bottomed at 0.09% in Q2 2025.
- A 5-year average of 0.03% and a median of 0.01% in 2023 frame the typical range for Return on Assets.
- Annual changes were most pronounced in 2021 — Return on Assets changed 0 bps — and 2025, when it dropped 7 bps.
- Greenwich LifeSciences' Return on Assets stood at 0.0% in 2021, then plunged by 423 bps to 0.01% in 2022, then plunged by 47 bps to 0.02% in 2023, then plunged by 192 bps to 0.05% in 2024, then retreated by 18 bps to 0.06% in 2025.
- Business Quant data shows GLSI's Return on Assets at 0.06% in Q4 2025, 0.08% in Q3 2025, and 0.09% in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -0.69% |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 0.00% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -0.01% |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 0.00% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 0.00% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | -0.80% |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 0.00% |
| 10 | Greenwich LifeSciences | 178.53 Mn | 178.53 Mn | - | -0.06% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -0.06% |
| Sep 30, 2025 | -0.08% |
| Jun 30, 2025 | -0.09% |
| Mar 31, 2025 | -0.07% |
| Dec 31, 2024 | -0.05% |
| Sep 30, 2024 | -0.02% |
| Jun 30, 2024 | -0.02% |
| Mar 31, 2024 | -0.02% |
| Dec 31, 2023 | -0.02% |
| Sep 30, 2023 | -0.01% |
| Jun 30, 2023 | -0.01% |
| Mar 31, 2023 | -0.01% |
| Dec 31, 2022 | -0.01% |
| Sep 30, 2022 | -0.01% |
| Jun 30, 2022 | -0.01% |
| Mar 31, 2022 | 0.00% |
| Dec 31, 2021 | 0.00% |
| Sep 30, 2021 | 0.00% |
| Jun 30, 2021 | 0.00% |
| Mar 31, 2021 | 0.00% |